private:thomasmcnerney&partners
|
3070249
|
Jun 4th, 2019 12:00AM
|
Thomas, McNerney & Partners
|
179
|
5.00
|
Open
|
Venture Capital & Private Equity
|
Jun 3rd, 2019 10:24PM
|
Jun 3rd, 2019 10:24PM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
Open
|
Life Science and Medical Technology
|
Open
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 17th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 16th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 15th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 14th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 13th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 12th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 11th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 10th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|
private:thomasmcnerney&partners
|
3070249
|
Feb 9th, 2018 12:00AM
|
Thomas, McNerney & Partners
|
161
|
6.00
|
Open
|
Venture Capital & Private Equity
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Thomas, McNerney & Partners is a health care venture firm that invests in life science and medical technology companies at all stages of development. The firm is distinguished from other health care funds by the multi-stage investment expertise of its partners and their long, successful investment track records. The firm targets investments in the pharmaceutical, medical device, biotechnology and diagnostic sectors, as well as in other areas that utilize medical technology innovation. In addition to providing growth capital to emerging companies to advance clinical development or for product commercialization, the partnership has significant experience spinning out products and divisions from major medical device and pharmaceutical companies, consolidating companies through roll-up strategies, participating in structured financings for public companies and leading recapitalizations. The firm also has a strong track record of helping entrepreneurs launch companies with seed and early stage funding.
Thomas, McNerney & Partners has a nationwide footprint, with offices on the East Coast, in the Midwest and on the West Coast, and currently has approximately $600 million under management.
|
|
|
|
|
|
|
|
|
|
Thomas, McNerney & Partners
|
|
Pharmaceuticals & Biotechnology
|